The First Clinical College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, China.
School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, China.
Chin J Integr Med. 2023 Jul;29(7):634-643. doi: 10.1007/s11655-023-3639-7. Epub 2023 May 24.
High mortality rates from cardiovascular diseases (CVDs) persist worldwide. Older people are at a higher risk of developing these diseases. Given the current high treatment cost for CVDs, there is a need to prevent CVDs and or develop treatment alternatives. Western and Chinese medicines have been used to treat CVDs. However, several factors, such as inaccurate diagnoses, non-standard prescriptions, and poor adherence behavior, lower the benefits of the treatments by Chinese medicine (CM). Artificial intelligence (AI) is increasingly used in clinical diagnosis and treatment, especially in assessing efficacy of CM in clinical decision support systems, health management, new drug research and development, and drug efficacy evaluation. In this study, we explored the role of AI in CM in the diagnosis and treatment of CVDs, and discussed application of AI in assessing the effect of CM on CVDs.
心血管疾病(CVDs)的死亡率在全球范围内仍然很高。老年人患这些疾病的风险更高。鉴于 CVDs 的当前高治疗成本,有必要预防 CVDs 或开发治疗替代方法。西药和中药已被用于治疗 CVDs。然而,一些因素,如不准确的诊断、非标准处方和较差的依从性行为,降低了中药(CM)治疗的效果。人工智能(AI)越来越多地用于临床诊断和治疗,特别是在评估 CM 在临床决策支持系统、健康管理、新药研发和药物疗效评价中的疗效方面。在这项研究中,我们探讨了 AI 在 CVDs 的 CM 诊断和治疗中的作用,并讨论了 AI 在评估 CM 对 CVDs 的影响中的应用。